Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association naming David Cullinane .
Filed returns
19
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | Access to medicines in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | Number of Clinical Trials in Ireland (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2026 | Irish Pharmaceutical Healthcare Association | Health | Moving Codeine containing OTC medicines from pharmacy only to prescription. (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | Moving Codeine containing OTC medicines from pharmacy only to prescription. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Legislation) | 10 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | IPHA General Election Manifesto asks - (i) Faster Access to new Medicines and (ii) Increased number of Clinical Trials. (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) | 13 | On lobbying.ie |
| May–Aug 2024 | Irish Pharmaceutical Healthcare Association | Health | IPHA General Election Manifesto asks (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | General discussion on issues regarding the reimbursement of medicines in Ireland and the European Commission proposed revision of the EU General Pharmaceutical Legislation. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) European Commission's proposed revision of EU Pharma Legislation and related matters, with particular attention to intellectual property rights provisions and competitiveness. (2) General discussion on issues… (Legislation) | 2 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | Raise awareness about the European Commission's revision of the EU Pharmaceutical Strategy and IPHA's key asks for the next European Parliament mandate. (Legislation) | 10 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) Budget 2024 - the need for funding of new medicines. (2) Likely no provision for new developments funding to HSE for new medicines in Budget 2024. (3) Absence of funding for new medicines in Budget 2024. (4)… (Matters involving public funds) | 34 | On lobbying.ie |
| Sep–Dec 2023 | Irish Pharmaceutical Healthcare Association | Health | Review of EU Council and Parliament process for proposed amendments to pharmaceutical legislation. (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | Request meeting on improved transparency in the context of Sinn Féin's Healthcare (Transparent Payments) Bill 2022. (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | EU Policy matters and fast access for new and innovative medicines. (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2022 | Irish Pharmaceutical Healthcare Association | Health | (i) EU Pharmaceutical Policy; (ii) EFPIA WAIT Indicator Survey - Access to new medicines; (iii) Access to Orphan Medicines; (iv) EU Pharmaceutical Strategy (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines & new supply agreement (Matters involving public funds) | 9 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 19 | 100.0% |